文献速递新发突发、热带与寄生虫病

登革病毒不显性感染与埃及伊蚊唾液蛋白抗体水平升高相关:柬埔寨登革热纵向队列研究

Development of Inapparent Dengue Associated With Increased Antibody Levels to Aedes aegypti Salivary Proteins: A Longitudinal Dengue Cohort in Cambodia.
PubMed 文献 · J Infect Dis · 2022-01-01

本研究在柬埔寨建立首个前瞻性儿童队列PAGODAS,纳入2-9岁儿童771名,每半年随访检测登革病毒和埃及伊蚊唾液腺匀浆蛋白抗体。至2020年4月,51名儿童发生症状性登革热,148名登革热初筛阴性儿童发生不显性登革热。对埃及伊蚊唾液蛋白抗体较高者发生登革感染的风险为1.47倍,不显性登革热风险为1.64倍。

要点

  • 对埃及伊蚊唾液蛋白抗体较高者发生登革感染的风险增加,主要为不显性感染。
  • 基线时22%(173/770)儿童对1种或以上登革血清型有中和抗体证据。
  • 随访至2020年4月,51名儿童发生症状性登革热,148名登革热初筛阴性儿童发生不显性登革热。

核心结论

  • 对埃及伊蚊唾液蛋白的高血清阳性水平与登革热初筛阴性柬埔寨儿童未来发生登革感染相关,且主要为不显性感染。

研究设计与样本

  • 前瞻性队列研究PAGODAS(Pediatric Assessment Group of Dengue and Aedes Saliva),纳入2-9岁儿童,经监护人知情同意入组,每半年随访检测登革病毒和埃及伊蚊唾液腺匀浆蛋白抗体(酶联免疫吸附试验)及登革特异性中和滴度,任何时间发热即进行登革检测。

主要发现

  • 2018年7月13日至8月30日共纳入771名儿童,基线时22%(173/770)对1种或以上登革血清型有中和抗体证据。
  • 至2020年4月,51名儿童发生症状性登革热,148名登革热初筛阴性儿童经中和试验定义发生不显性登革热。
  • 多变量模型中,对埃及伊蚊唾液蛋白抗体较高者发生登革感染的风险为1.47倍(HR 1.47,95%CI 1.05-2.06,P=.02),不显性登革热风险为1.64倍(HR 1.64,95%CI 1.12-2.41,P=.01)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We established the first prospective cohort to understand how infection with dengue virus is influenced by vector-specific determinants such as humoral immunity to Aedes aegypti salivary proteins. METHODS: Children aged 2-9 years were enrolled in the PAGODAS (Pediatric Assessment Group of Dengue and Aedes Saliva) cohort with informed consent by their guardians. Children were followed semi-annually for antibodies to dengue and to proteins in Ae. aegypti salivary gland homogenate using enzyme-linked immunosorbent assays and dengue-specific neutralization titers. Children presented with fever at any time for dengue testing. RESULTS: From 13 July to 30 August 2018, we enrolled 771 children. At baseline, 22% (173/770) had evidence of neutralizing antibodies to 1 or more dengue serotypes. By April 2020, 51 children had symptomatic dengue while 148 dengue-naive children had inapparent dengue defined by neutralization assays. In a multivariate model, individuals with higher antibodies to Ae. aegypti salivary proteins were 1.5 times more likely to have dengue infection (hazard ratio [HR], 1.47 [95% confidence interval {CI}, 1.05-2.06]; P = .02), particularly individuals with inapparent dengue (HR, 1.64 [95% CI, 1.12-2.41]; P = .01). CONCLUSIONS: High levels of seropositivity to Ae. aegypti salivary proteins are associated with future development of dengue infection, primarily inapparent, in dengue-naive Cambodian children. CLINICAL TRIALS REGISTRATION: NCT03534245.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Manning JE, Chea S, Parker DM, et al. Development of Inapparent Dengue Associated With Increased Antibody Levels to Aedes aegypti Salivary Proteins: A Longitudinal Dengue Cohort in Cambodia. J Infect Dis. 2022. PMID: 34718636. doi:10.1093/infdis/jiab541

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。